Terms: = Leukemia AND KMT2C, ENSG00000055609, MLL3, 58508 AND Prognosis
10 results:
1. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
[TBL] [Abstract] [Full Text] [Related]
2. Advances in the Treatment of Hairy Cell leukemia Variant.
Tran J; Gaulin C; Tallman MS
Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
[TBL] [Abstract] [Full Text] [Related]
3. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract] [Full Text] [Related]
4. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract] [Full Text] [Related]
5. Clinical impact of kmt2c and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients.
Kayser S; Feszler M; Krzykalla J; Schick M; Kramer M; Benner A; Thol F; Platzbecker U; Müller-Tidow C; Ho AD; Ehninger G; Heuser M; Schlenk RF; Thiede C; Röllig C; Krämer A
Eur J Haematol; 2017 Dec; 99(6):544-552. PubMed ID: 28940816
[TBL] [Abstract] [Full Text] [Related]
6. Expression Levels of kmt2c and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
Sato K; Akimoto K
Clin Breast Cancer; 2017 Jun; 17(3):e135-e142. PubMed ID: 27986439
[TBL] [Abstract] [Full Text] [Related]
7. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
[TBL] [Abstract] [Full Text] [Related]
8. Association of mll3 expression with prognosis in gastric cancer.
Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
Genet Mol Res; 2014 Sep; 13(3):7513-8. PubMed ID: 25222251
[TBL] [Abstract] [Full Text] [Related]
9. mll3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
Chen C; Liu Y; Rappaport AR; Kitzing T; Schultz N; Zhao Z; Shroff AS; Dickins RA; Vakoc CR; Bradner JE; Stock W; LeBeau MM; Shannon KM; Kogan S; Zuber J; Lowe SW
Cancer Cell; 2014 May; 25(5):652-65. PubMed ID: 24794707
[TBL] [Abstract] [Full Text] [Related]
10. Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report.
Valentine MC; Linabery AM; Chasnoff S; Hughes AE; Mallaney C; Sanchez N; Giacalone J; Heerema NA; Hilden JM; Spector LG; Ross JA; Druley TE
Leukemia; 2014 Jun; 28(6):1235-41. PubMed ID: 24301523
[TBL] [Abstract] [Full Text] [Related]
